Medication Practice of Patients with Dermatophytosis

Authors

  • Yogesh Poudyal Department of Dermatology and Venereology, Universal college of Medical Sciences, Bhairahawa, Nepal.
  • Shambhu Dutta Joshi Department of Dermatology and Venereology, Dr. iwamura Memorial Hospital and research center, Bhaktapur, Nepal.

DOI:

https://doi.org/10.31729/jnma.2830

Keywords:

dermatophytosis; steroid; tinea.

Abstract

Introduction: Dermatophytosis is one of the commonest dermatoses observed in Dermatology OPD. It is caused by Fungus Dermatophyte. Its pattern and prevalence varies from region to region. As self medication practice is very common, we aim to find the prevalence of various clinical pattern of dermatophytosis and to find out the medication commonly used by the patients for this condition.
Methods: This was cross sectional observational study. The case collection was done from outpatient department of Dermatology and Venereology of a Teaching Hospital from 15th March, 2013 to 14March, 2014. Demographic, Clinical and other relevant details were recorded in Proforma after history and examination.
Results: The total number of cases were 594. Crural area was the most commonly involved. Tinea corporis was most common dermatophytosis followed by Tinea incognito. Risk of recurrence was highest in buttocks [odds ratio-2.404 (1.510, 3.827) and crural area [odds ratio- 2.298 (1.637,3.266). Topical steroid and topical steroid with antifungal was used by 225 (30.1%) and 226 (30.2%) respectively. Patients who consulted dermatologist were more likely to use antifungal, odds ratio- 12.060 (4.907, 29.643).
Conclusions: Tinea corporis was the commonest dermatophytosis. Due to practice of topical steroid misuse T. incognito was second common. It is essential to educate the general public, pharmacist and paramedics regarding the proper use of topical steroid. 
Keywords: dermatophytosis; steroid; tinea. | PubMed

References

Pires CAA, Cruz NFS, Lobato AM, Sousa PO, Carneiro
FRO,Mendes AMD. Clinical, epidemiological and
therapeutic profile dermatophytosis. An Bras Dermatol.
2014;89(2):259-264.
2. Wille MP, Arantes TD, Monteiroda Silva JL. Epidemiology of
dermatomycosis in population in the outskirts of Araraquara.
Rev Bras Clin Med. 2009;7:295-98
3. Walker SL, Shah M, Hubbard VG, Pradhan HM, Ghimire
M. Skin disease is common in rural Nepal: result of point
prevalence study. BJD. 2008;158:334-38
4. Dichiacchio N, Madeira CL, Humaire CR, Silva CS, Fernandes
LHG, Reis ALD. Superficial mycosis at the Hospital do
Servidor Publico municipal de sao Paulo between 2005 and
2011. An Bras Dermatol. 2014;89:67-71.
5. Asticcioli S, Silverio AD, Sacco L, Fusi I, Vincenti L, Ramero
E. Dermatophyte infection in patients attending tertiary care
hospital in Italy. New Microbiologica. 2008;31:543-48.
6. Flores JM, Castillo VB, Franco FC, Huata AB. Superficial
fungal infection: clinical and epidemiological study in
adolescent from marginal districts of Lima and Callao, Peru.
J infect Dev Ctries. 2009;3(4):313-17.
7. Mahmoudabadi AZ. A study of Dermatophytosis in south
west of Iran. Mycopathologia. 2005;160:21-24.
8. Aghamirian MR, Ghiasian SA. Dermatophytosis in
outpatients attending the dermatology center of Avicenna
Hospital in Qiazvin, Iran. Mycoses. 2007;51:155-60.
9. Aboueisha AM, El-Mahallawy H. Public health significance
of dermatophytes in Ismailia and port said province, Egypt.
Med Mycol J. 2013;54:123-29.
10. Biswas A, Sen S, Pal A, Das J, Das S, Tripathi SK. Self
medicational trend among the urban elderly- a cross
sectional observational study. Asian Journal of medical
sciences. 2015;6(5):66-68.
11. Awad AI, Eltayeb IB,Capps PA. Self medication practices in
Khartoum state, sudan. Eur J Clin Pharmacol. 2006;62:317-24.
12. Correa-Fissmer M, Mendonca MG, Martins AH, Galate D.
Prevalence of self medication for skin diseases:a systematic
review. An Bras Dermatol. 2014;89(4):625-30.
13. Al-Dhalimi MA, Alijawahiry N. Misuse of topical
corticosteroids: a clinical study in an Iraqi hospital. East
mediterr health J. 2006;12(6):847-52.
14. Mathur M, kedia SK, Ghimire RB. ‘Epizoonosis of
dermatophytosis’ a clinic-mycological study of dermatophytic
infection in cemtral Nepal. KUMJ. 2012;10(37): 30-33.
15. Dinkela A, Ferie J, Mibata M, Schmid-Grendelmeier M,
Hartz C. Efficacy of triclosan soap against superficial
dermatomycosis: a double blind clinical trial in 224 primary
school children in kilombero district, Morogoro region
Tanzania. Int J Dermatol. 2007;46(suppl 2):23-28.
16. Metintas S, Kiraz N, Arslantas D, Akgun Y, Kalyoncu C, et
al. Frequency and risk factors of dermatophytosis in students
living in rural areas in Eskisehir, Turkey. Mycopathologia.
2004;157:379-82.
17. Poudyal Y, Rajbhandari SL. Pattern of skin disease in patient
visiting universal college of medical sciences-Teaching
Hospital (UCMS-TH) from the three districts of terai region
in Nepal. JUCMS. 2014;2(3):3-8.

Downloads

Published

2016-09-30

How to Cite

Poudyal, Y., & Joshi, S. D. (2016). Medication Practice of Patients with Dermatophytosis. Journal of Nepal Medical Association, 55(203), 07–10. https://doi.org/10.31729/jnma.2830

Issue

Vol. 55 No. 203 (2016)

Section

Original Article

License

JNMA allow to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. The author(s) are allowed to retain publishing rights without restrictions. The JNMA work is licensed under a Creative Commons Attribution 4.0 International License. More about Copyright Policy.